Ligand profile
ZINC13817026
Virtual-screening candidate from ZINC.
Bound to: KP13_00619 — Phosphatase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC13817026- UniProt (similar protein)
P34913- Tanimoto
- 0.750
- Target protein
- KP13_00619
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 116.5
- −1 ≤ LogP ≤ 5 4.80
- MW ≤ 500 Da 456.5
- LogP ≤ 5 4.80
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 8
- TPSA ≤ 140 Ų 116.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C=C(C)[C@H](CCC(C)(C)O)Cc1c(O)cc(OC)c2c1O[C@H](c1ccc(O)cc1O)CC2=OC=C(C)[C@H](CCC(C)(C)O)Cc1c(O)cc(OC)c2c1O[C@H](c1ccc(O)cc1O)CC2=O
InChI=1S/C26H32O7/c1-14(2)15(8-9-26(3,4)31)10-18-20(29)12-23(32-5)24-21(30)13-22(33-25(18)24)17-7-6-16(27)11-19(17)28/h6-7,11-12,15,22,27-29,31H,1,8-10,13H2,2-5H3/t15-,22+/m1/s1InChI=1S/C26H32O7/c1-14(2)15(8-9-26(3,4)31)10-18-20(29)12-23(32-5)24-21(30)13-22(33-25(18)24)17-7-6-16(27)11-19(17)28/h6-7,11-12,15,22,27-29,31H,1,8-10,13H2,2-5H3/t15-,22+/m1/s1
XMUPAAIHKAIUSU-QRQCRPRQSA-NXMUPAAIHKAIUSU-QRQCRPRQSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- J0U
- Homolog
- P34913
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC13817026 →
- ZINC ZINC20 ZINC13817026 →
- UniProt UniProt P34913 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC13817026”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00619.
PDB 104
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).